TY  - JOUR
AU  - Dávila-Seijo, Paula
AU  - Dauden, Esteban
AU  - Descalzo, M A
AU  - Carretero, Gregorio
AU  - Carrascosa, José-Manuel
AU  - Vanaclocha, Francisco
AU  - Gómez-García, Francisco-José
AU  - De la Cueva-Dobao, Pablo
AU  - Herrera-Ceballos, Enrique
AU  - Belinchón, Isabel
AU  - López-Estebaranz, José-Luis
AU  - Alsina, Merce
AU  - Sánchez-Carazo, José-Luis
AU  - Ferrán, Marta
AU  - Torrado, Rosa
AU  - Ferrandiz, Carlos
AU  - Rivera, Raquel
AU  - Llamas, Mar
AU  - Jiménez-Puya, Rafael
AU  - García-Doval, Ignacio
AU  - BIOBADADERM Study Group
PY  - 2016
DO  - 10.1016/j.jid.2016.08.034
UR  - http://hdl.handle.net/10668/10479
T2  - The Journal of investigative dermatology
AB  - Information regarding the safety of biological drugs prescribed to psoriasis patients on daily and long-term bases is insufficient. We used data from the BIOBADADERM registry (Spanish Registry of Adverse Events for Biological Therapy in Dermatological...
LA  - en
KW  - Adalimumab
KW  - Adult
KW  - Aged
KW  - Bacterial Infections
KW  - Biological Products
KW  - Cyclosporine
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Poisson Distribution
KW  - Psoriasis
KW  - Registries
TI  - Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.
TY  - research article
VL  - 137
ER  -